Plus Therapeutics Inc Revenue 2009–2025
Plus Therapeutics Inc annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Plus Therapeutics Inc revenue for the quarter ending March 31, 2026 was 1.0 M, a 2.93% decrease year-over-year.
- Plus Therapeutics Inc revenue for the twelve months ending March 31, 2026 was 4.9 M, a 4.71% decrease year-over-year.
- Plus Therapeutics Inc annual revenue for 2025 was 5.2 M, a 10.49% decrease from 2024.
- Plus Therapeutics Inc annual revenue for 2024 was 5.8 M, a 18.54% increase from 2023.
- Plus Therapeutics Inc annual revenue for 2023 was 4.9 M, a 33.83% increase from 2018.
- Plus Therapeutics Inc annual revenue for 2018 was 3.7 M.
Plus Therapeutics Inc (PSTV) — Frequently Asked Questions
Plus Therapeutics Inc (PSTV) is a publicly traded US company. It has a market capitalization of $419M. In fiscal 2025 it reported revenue of $5M and net income of -$22M. Explore PSTV's stock price, financial statements, earnings history, margins and key ratios below.
What is Plus Therapeutics Inc's market cap?
Plus Therapeutics Inc (PSTV) has a market capitalization of $419M.
What is the PSTV stock price?
PSTV trades at $5.39 (-2.00% on the day).
How much revenue does Plus Therapeutics Inc make?
Plus Therapeutics Inc reported revenue of $5M in fiscal 2025.
Is PSTV profitable?
In fiscal 2025, Plus Therapeutics Inc reported net income of -$22M.